Open access
Nov 2026
Association Between Plasma N-Terminal Tau, Cognitive Decline, and Neurodegeneration in the ADNI Cohort.
BACKGROUND AND OBJECTIVES Blood-based biomarkers offer a cost-effective, minimally invasive alternative to neuroimaging and CSF biomarkers. Newly developed fluid biomarkers, including the N-terminal tau fragment (NT1), show promise for identifying individuals at risk for Alzheimer disease (AD) and for monitoring diseas...
Yi-Wen Rao, Lei Liu, B. Ostaszewski et al.
· Neurology · 0 citations